BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//XIMA Media GmbH//xima_typo3_calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:entry-275@www.dkfz.de
DTSTAMP:20260929T144641Z
DTSTART:20250612T070000Z
DTEND:20250612T080000Z
SUMMARY:Distinguished Lecturer Seminar Series - Thijn Brummelkamp "Genetics
  in Human Cells to identify ‘Alternative Pathways"
DESCRIPTION:Thijn Brummelkamp is Director of Research at the Netherlands Ca
 ncer Institute with a research interest in the fields of cell and cancer b
 iology. He is known for pioneering technologies such as short hairpin RNAs
  (shRNAs) and the development of haploid human cells as a genetic model sy
 stem. Brummelkamp studied biology at the Free University of Amsterdam and 
 conducted his Ph.D. research at the Netherlands Cancer Institute\, earning
  his doctorate from Utrecht University. He then joined the Whitehead Insti
 tute for Biomedical Research in Cambridge\, USA\, as a Whitehead Fellow\, 
 where he established his independent research laboratory. In 2011\, he ret
 urned to the Netherlands Cancer Institute as a group leader and co-founded
  the biotech companies Haplogen and Scenic Biotech. He currently holds app
 ointments as a group leader at the Oncode Institute and as Professor of Ex
 perimental Genetics at Utrecht University. Brummelkamp was named one of MI
 T Technology Review’s Top 35 Innovators Under 35 in 2005\, received the 
 Kimmel Scholar Award in 2006\, and was awarded the EMBO Gold Medal in 2013
 . Brummelkamp is also a member of the Royal Netherlands Academy of Arts an
 d Sciences (KNAW)
LOCATION:DKFZ Communication Center\, Hörsaal
URL:https://www.dkfz.de/aktuelles/veranstaltungen/detail/84-distinguished-l
 ecturer-seminar-series-thijn-brummelkamp-genetics-in-human-cells-to-identi
 fy-alternative-pathways/a275
CATEGORIES:Vorträge und Seminare
ORGANIZER;CN="Martina Jochim":mailto:m.jochim@dkfz-heidelberg.de
STATUS:CONFIRMED
SEQUENCE:1790690401
LAST-MODIFIED:20260929T140001Z
END:VEVENT
END:VCALENDAR